Assess whether related-party sales should be backed out of valuation (84dc7e)
August 31, 2026
SITUATION A strategic buyer looking at a carve-out from a conglomerate cannot treat a CIM that omitted a material litigation as incidental context on management-team retention and key-person map. Working-capital true-up analyst must close related-party sales should be from that extract under M&A Due Diligence / Legal, IP, and Regulatory.
DECISION Working-capital true-up analyst in a strategic buyer looking at a carve-out from a conglomerate must choose Proceed / Reprice / Walk / Hold using management-team retention and key-person map after a CIM that omitted a material litigation.
HYPOTHESES TO TEST 1. A CIM that omitted a material litigation is noise around an already-controlled Legal, IP, and Regulatory process in a strategic buyer looking at a carve-out from a conglomerate, given management-team retention and key-person map. 2. A CIM that omitted a material litigation is the event in management-team retention and key-person map that forces Proceed for working-capital true-up analyst under M&A Due Diligence. 3. Management-team retention and key-person map shows a one-file miss after a CIM that omitted a material litigation, not a Legal, IP, and Regulatory program failure. 4. Management-team retention and key-person map cannot decide related-party sales should be yet after a CIM that omitted a material litigation; hold is the only M&A Due Diligence close a strategic buyer looking at a carve-out from a conglomerate can defend.
ANALYSIS REQUIRED 1. Test whether a CIM that omitted a material litigation is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in management-team retention and key-person map. 3. Map reps, earnout mechanics, and integration risk a strategic buyer looking at a carve-out from a conglomerate would inherit. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read management-team retention and key-person map against a CIM that omitted a material litigation and write the one fact that would move related-party sales should be for working-capital true-up analyst.
RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (management-team retention and key-person map after a CIM that omitted a material litigation). Lead with the M&A Due Diligence option management-team retention and key-person map can support after a CIM that omitted a material litigation, then the two facts that force it, then the Monday action for working-capital true-up analyst in a strategic buyer looking at a carve-out from a conglomerate.
COMMAND RETURNS - Bottom-line M&A Due Diligence option on related-party sales should be, then the evidence in management-team retention and key-person map, then the action for working-capital true-up analyst - Hypothesis scorecard against management-team retention and key-person map: supported / rejected / untestable - Named option among Proceed, Reprice, Walk and the fact that kills the others - Owner and next date for working-capital true-up analyst in a strategic buyer looking at a carve-out from a conglomerate
Explore more
More M&A Due Diligence prompts
- Assess whether to re-trade, restructure, or drop (37ba4a)
- Assess whether environmental liability is capped or open-ended (271223)
- Assess whether management can run this without the founder (5daa7f)
- Assess whether regulatory approval is a timing risk or a deal risk (a3623f)
- Assess whether earnings quality supports the bid price (32ee01)
Explore related decision areas
- Assess whether to quote, refer, or decline (d16ed9)Insurance Underwriting
- Assess whether product recall exposure is priced or excluded (d984b3)Insurance Underwriting
- Assess whether the pattern is timing, error, or scheme (35d1f0)Forensic Accounting
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

